Ninlib 150mg Capsule: Effective Relief for Your Needs

Uses:

• Treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph-positive CML) in adults and pediatrics, including newly diagnosed patients and those experiencing side effects from previous treatment.

Therapeutic Effects:

• BCR-ABL tyrosine kinase is responsible for the uncontrolled division of cells in CML. Ninlib 150mg disrupts the signaling route of the protein kinase enzyme, targeting the BCR-ABL protein and inhibiting the growth and spread of cancer cells.

Important Safety Information:

• Pregnancy and Breastfeeding: Ninlib 150mg is unsafe to use during pregnancy unless necessary. Consult your doctor before starting treatment. Taking Ninlib 150mg while breastfeeding may be unsafe; consult your doctor.
• Liver Conditions: Inform your physician if you have liver problems. Ninlib 150mg should be used cautiously with this condition.
• Other Medications: Inform your healthcare professional about all the medicines you take, including prescription, over-the-counter, nutritional and vitamin supplements, and herbal products.
• Alcohol: It is unknown whether consuming alcohol while taking Ninlib 150mg is safe. Speak with your physician.
• Driving: While taking Ninlib 150mg, it is unsafe to drive or use machines because it may cause nausea, changes in vision, vomiting, etc.

Side Effects:

• Serious: Sudden weight gain, swelling in hands, feet, ankles, or face, chest pain, blood pressure (high and low), discoloration of tongue, lips, or skin (blue), abnormal heart (irregular heartbeat), hair loss, vision problems, stomach pain, vomiting of blood, blood in stools, yellowing of the skin, eyes, and dark urine, high blood sugar levels, sensitivity to light.
• Common: Nausea, vomiting, diarrhoea, headache, muscle pain, stomach pain, hair loss, tiredness, constipation, slowing of growth in children, pneumonia, loss of appetite, sleeplessness, depression, and anxiety, stomach discomforts like bloating and flatulence after meals, musculoskeletal pain.

FAQ:

• Q 1. Can Ninlib 150mg cause liver damage?
  • Ninlib 150mg may cause liver function abnormalities, which may indicate liver damage. Regular blood tests are necessary to monitor liver function.
• Q 2. How does Ninlib 150mg differ from other medications used to treat chronic myeloid leukemia, such as Imatinib?
  • Ninlib 150mg is more selective for the BCR-ABL protein that drives the growth of cancer cells, and it is more potent in inhibiting the activity of this protein. It has been shown to be effective in patients who have developed resistance to Imatinib.
• Q 3. What are the potential long-term effects of Ninlib 150mg on the body?
  • The potential long-term effects include cardiovascular events, liver dysfunction, pancreatic enzyme elevation, and fluid retention. These side effects are generally rare but can occur in some patients.
• Q 4. How to monitor the effects of Ninlib 150mg over the course of treatment?
  • Monitoring includes regular blood tests, electrocardiograms, and imaging studies. Blood tests assess liver and kidney function, blood counts, and electrolyte levels. ECG detects changes in heart rhythm or function. Imaging studies evaluate the heart and lungs.
• Q 5. Who should not take Ninlib 150mg?
  • Ninlib 150mg should not be taken by pregnant or breastfeeding women, or by people with severe liver or kidney disease, a history of pancreatitis, or a prolonged QT interval.

Fact Box:

• Molecule name: Nilotinib
• Therapeutic class: Antineoplastic drug
• Pharmacological class: Tyrosine Kinase inhibitors
• Indications: Blood cancer (Philadelphia chromosome-positive chronic myeloid leukemia) in adults and pediatrics.

Tags: Ninlib150mg, Capsule, Medication, HealthProduct, PharmaceuticalProduct